Get the Stockscreener App
0.9102
1.98%
0.0177
After Hours:
.94
0.0298
+3.27%
Tiziana Life Sciences Ltd stock is traded at $0.9102, with a volume of 114.42K.
It is up +1.98% in the last 24 hours and down -22.86% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
See More
Previous Close:
$0.8925
Open:
$0.9328
24h Volume:
114.42K
Relative Volume:
0.50
Market Cap:
$115.83M
Revenue:
-
Net Income/Loss:
$-18.43M
P/E Ratio:
-5.8421
EPS:
-0.1558
Net Cash Flow:
$-12.87M
1W Performance:
-10.33%
1M Performance:
-22.86%
6M Performance:
-46.46%
1Y Performance:
-51.06%
1-Day Range:
$0.91
$0.9459
1-Week Range:
$0.8663
$1.09
52-Week Range:
$0.8663
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
0.9102 | 113.58M | 0 | -18.43M | -12.87M | -0.1558 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Tiziana Life Sciences Ltd (TLSA) Institutional Confidence - TradingKey
Tiziana Life Sciences Ltd (TLSA) Cash Flow - TradingKey
Tiziana Life Sciences Ltd (TLSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tiziana Life Sciences Ltd (TLSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TLSA|Tiziana Life Sciences Ltd|Price:0.932|Chg%:+0.040 - TradingKey
Tiziana Life Sciences Ltd (TLSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tiziana Life Sciences Ltd (TLSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tiziana Life Sciences Ltd (TLSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TLSA|Tiziana Life Sciences Ltd|Price:0.892|Chg%:-0.128 - TradingKey
TradingKey - TradingKey
Tiziana Life Sciences Ltd. Revenue Breakdown – FWB:0RP - TradingView
Tiziana Life Sciences Ltd. Revenue Breakdown – GETTEX:0RP - TradingView
Tiziana Life Sciences (TLSA) insider awarded 42,357 shares of common stock - Stock Titan
Tiziana Life Sciences (TLSA) Executive Chairman Increases Stake - GuruFocus
Tiziana Life Sciences says executive chairman increased stake with share purchase - Proactive financial news
Tiziana Life Sciences Chairman Boosts Stake to Nearly 35% in July Share Purchase - TipRanks
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - The Manila Times
Tiziana Life Sciences (Nasdaq: TLSA) chair lifts holding to 34.93% stake - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
symbol__ Stock Quote Price and Forecast - CNN
Keeren Rameshchandra Shah Net Worth (2026) - GuruFocus
Enterprise value to EBITDA forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Price to book forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Price to sales forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Enterprise value to revenue forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (DUS:0RP) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (NASDAQ:TLSA) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (FWB:0RP) - TradingView
TLSA Forecast — Price Target — Prediction for 2027 - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (TRADEGATE:0RP) - TradingView
Small cap wrap: Power Metallic Mines, Tiziana Life Sciences, Fox Tungsten, American Resources… - Proactive financial news
0RP Forecast — Price Target — Prediction for 2027 - TradingView
Could Intranasal Innovation Shape the Future of Multiple Sclerosis Care? - Kalkine Media
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada
Tiziana Life Sciences (TLSA) Advances Clinical Trial for Multiple Sclerosis Treatment - GuruFocus
Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Potential Multiple Sclerosis Treatment - Moomoo
Tiziana (Nasdaq: TLSA) completes enrollment in Phase 2a INFORM-MS study - Stock Titan
Tiziana Life Sciences Ltd (TLSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Why Tiziana Life Sciences Is Back on the Small-Cap Radar? - Kalkine Media
Tiziana Life Sciences Ltd (TLSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tiziana Life Sciences (TLSA) insider awarded 15,000 common shares - Stock Titan
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance - The Globe and Mail
Tiziana Life Sciences Ltd announced that it has received $0.01665 million in funding - marketscreener.com
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Stake wit - GuruFocus
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Shareholding - GuruFocus
Tiziana executive chairman increases stake - Proactive financial news
Tiziana (NASDAQ: TLSA) chair lifts stake with 15,000-share purchase - Stock Titan
Founder now owns 34.89% of Tiziana Life Sciences after 15K-share buy - Stock Titan
Tiziana Life Sciences (TLSA) Retreats 2.6% as Shares Approach Key SupportGolden Cross - newsline.com
[6-K] Tiziana Life Sciences Ltd Current Report (Foreign Issuer) | TLSA SEC FilingForm 6-K - Stock Titan
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):